Evidence map›Paper›PMID 38318142›Full record

ArticleFrontiers in pharmacology2024

Efficacy and pharmacoeconomic advantages of Fufang Huangbai Fluid hydropathic compress in diabetic foot infections: a comparative clinical study with antimicrobial calcium alginate wound dressing.

Guangyao Yang, Gang Wang, Zhenghong Li, Lijuan Deng, Ning Wang, Xuewan Wang, Tong Zhou, Jingming Zhang, Yin Lei, Tao Wang and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Antimicrobial effects of compound Huangbai liquid onAmerican journal of translational research · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Guangyao YangBeijing Hepingli Hospital, Beijing, China.
Gang WangDepartment of Peripheral Vascular, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Zhenghong LiResearch Department, Swiss University of Traditional Chinese Medicine, Bad Zurzach, Switzerland.
Lijuan DengBeijing University of Chinese Medicine, Beijing, China.
Ning WangBeijing University of Chinese Medicine, Beijing, China.
Xuewan WangBeijing University of Chinese Medicine, Beijing, China.
Tong ZhouBeijing University of Chinese Medicine, Beijing, China.
Jingming ZhangBeijing Hepingli Hospital, Beijing, China.
Yin LeiBeijing Hepingli Hospital, Beijing, China.
Tao WangBeijing University of Chinese Medicine, Beijing, China.
Yue WangBeijing University of Chinese Medicine, Beijing, China.
Hanying ShaoBeijing University of Chinese Medicine, Beijing, China.
Mingya ChenBeijing University of Chinese Medicine, Beijing, China.
Keren ZhangBeijing University of Chinese Medicine, Beijing, China.
Min ZhouBeijing University of Chinese Medicine, Beijing, China.
Xiangbao WangDepartment of Interventional Center, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Xingfang LiuResearch Department, Swiss University of Traditional Chinese Medicine, Bad Zurzach, Switzerland.
Shang JuDepartment of Peripheral Vascular, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial efficacyChinese medicineclinical trialdiabetesFufang Huangbai Fluid (FFHB)pharmacoeconomics

Identifiers

PMID38318142
PMCPMC10839075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.